Skip to main content
logo
Exact Sciences Corporation (EXAS)
Mar 23, 2026 - EXAS was delisted (reason: acquired by ABT)
104.91
+0.99 (0.95%)
Inactive · Last trade price on Mar 20, 2026

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
3.02B2.57B
Outside of United States Revenue
223.84M189.09M
Revenue (Total)
3.25B2.76B

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Screening Medicare Parts B & C Revenue
955.08M776.16M
Screening Commercial Revenue
1.32B1.12B
Screening Other Service Revenue
251.58M209.38M
Total Screening Revenue
2.53B2.10B
Precision Oncology Medicare Parts B & C Revenue
196.47M187.95M
Precision Oncology Commercial Revenue
196.17M190.60M
Precision Oncology International Revenue
223.84M189.09M
Precision Oncology Other Service Revenue
100.64M87.36M
Total Precision Oncology Revenue
717.12M655.00M
Revenue (Total)
3.25B2.76B

EBT by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Income Before Tax
-220.01M-1.04B
Outside of United States Income Before Tax
16.12M145.00K